Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Robert D. Odze, M.D.,C.M.

TitleProfessor of Pathology
InstitutionBrigham and Women's Hospital
DepartmentPathology
AddressBrigham and Women's Hospital
Pathology
75 Francis St
Boston MA 02115
Phone617/732-7549
Fax617/278-6950

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Nazarian RM, Primiani A, Doyle LA, Linskey KR, Duncan LM, Odze RD, Zukerberg LR. Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus. Am J Surg Pathol. 2014 Jan; 38(1):78-85.
    View in: PubMed
  2. Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, Zlobec I, Karamitopoulou E, Stachler MD, Odze RD, Lencer WI, Jobin C, Blumberg RS. Neonatal Fc Receptor Expression in Dendritic Cells Mediates Protective Immunity against Colorectal Cancer. Immunity. 2013 Dec 12; 39(6):1095-107.
    View in: PubMed
  3. Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK, Maley CC, Self SG, Vaughan TL, Blount PL, Reid BJ. Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus. Cancer Prev Res (Phila). 2014 Jan; 7(1):114-27.
    View in: PubMed
  4. Odze RD. IBD: Role of the pathologist in the diagnosis and management of IBD. Nat Rev Gastroenterol Hepatol. 2013 Nov; 10(11):625-6.
    View in: PubMed
  5. Star KV, Ho VT, Wang HH, Odze RD. Histologic Features in Colon Biopsies Can Discriminate Mycophenolate From GVHD-induced Colitis. Am J Surg Pathol. 2013 Sep; 37(9):1319-28.
    View in: PubMed
  6. Khan S, McDonald SA, Wright NA, Graham TA, Odze RD, Rodriguez-Justo M, Zeki S. Crypt dysplasia in Barrett's oesophagus shows clonal identity between crypt and surface cells. J Pathol. 2013 Sep; 231(1):98-104.
    View in: PubMed
  7. Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, Jain R, Appalaneni V, Anderson MA, Ben-Menachem T, Chandrasekhara V, Chathadi K, Decker GA, Early D, Evans JA, Fanelli RD, Fisher DA, Fisher LR, Foley KQ, Hwang JH, Jue TL, Ikenberry SO, Khan KM, Lightdale J, Malpas PM, Maple JT, Pasha S, Saltzman J, Dominitz JA, Cash BD. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013 Aug; 78(2):216-24.
    View in: PubMed
  8. Kostadinov RL, Kuhner MK, Li X, Sanchez CA, Galipeau PC, Paulson TG, Sather CL, Srivastava A, Odze RD, Blount PL, Vaughan TL, Reid BJ, Maley CC. NSAIDs Modulate Clonal Evolution in Barrett's Esophagus. PLoS Genet. 2013 Jun; 9(6):e1003553.
    View in: PubMed
  9. Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD, Zaninotto G, Croce CM, Rugge Md Facg M. MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clin Transl Gastroenterol. 2013; 4:e34.
    View in: PubMed
  10. Quinn AM, Farraye FA, Naini BV, Cerda S, Coukos J, Li Y, Khor T, Odze RD. Polypectomy is Adequate Treatment for Adenoma-like Dysplastic Lesions (DALMs) in Crohn's Disease. Inflamm Bowel Dis. 2013 May; 19(6):1186-93.
    View in: PubMed
  11. Naini BV, Odze RD. Advanced precancerous lesions (APL) in the colonic mucosa. Best Pract Res Clin Gastroenterol. 2013 Apr; 27(2):235-56.
    View in: PubMed
  12. García-Varona A, Odze RD, Makrauer F. Lymphocytic colitis secondary to ipilimumab treatment. Inflamm Bowel Dis. 2013 Feb; 19(2):E15-6.
    View in: PubMed
  13. Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL. The Role of Tobacco, Alcohol, and Obesity in Neoplastic Progression to Esophageal Adenocarcinoma: A Prospective Study of Barrett's Esophagus. PLoS One. 2013; 8(1):e52192.
    View in: PubMed
  14. Odze RD. Histologic features of gastroesophageal reflux disease and eosinophilic esophagitis. Gastroenterol Hepatol (N Y). 2012 Jul; 8(7):472-3.
    View in: PubMed
  15. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012 Sep; 107(9):1315-29; quiz 1314, 1330.
    View in: PubMed
  16. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46.
    View in: PubMed
  17. Yang QH, Schmidt J, Soucy G, Odze R, Dejesa-Jamanila L, Arnold K, Kuslich C, Lash R. KRAS mutational status of endoscopic biopsies matches resection specimens. J Clin Pathol. 2012 Jul; 65(7):604-7.
    View in: PubMed
  18. Odze RD, Greenson J, Lauwers G, Goldblum J. Gastritis cystica profunda versus invasive adenocarcinoma. Am J Surg Pathol. 2012 Feb; 36(2):316.
    View in: PubMed
  19. Hamilton MJ, Rege TA, Odze RD. Adenocarcinoma complicating ulcerative colitis presenting as multiple pseudopolyp-like lesions. Clin Gastroenterol Hepatol. 2012 Jun; 10(6):xxv.
    View in: PubMed
  20. Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol. 2011 Sep; 35(9):1274-86.
    View in: PubMed
  21. Soucy G, Wang HH, Farraye FA, Schmidt JF, Farris AB, Lauwers GY, Cerda SR, Dendrinos KG, Odze RD. Clinical and pathological analysis of colonic Crohn's disease, including a subgroup with ulcerative colitis-like features. Mod Pathol. 2012 Feb; 25(2):295-307.
    View in: PubMed
  22. Gibson JA, Odze RD. Pathology of diseases that cause upper gastrointestinal tract bleeding. Gastrointest Endosc Clin N Am. 2011 Oct; 21(4):583-96.
    View in: PubMed
  23. Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol. 2011 Nov; 106(11):1899-908; quiz 1909.
    View in: PubMed
  24. Huang Q, Fan X, Agoston AT, Feng A, Yu H, Lauwers G, Zhang L, Odze RD. Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients. Histopathology. 2011 Aug; 59(2):188-97.
    View in: PubMed
  25. Doyle LA, Odze RD. Eosinophilic esophagitis without abundant eosinophils? The expanding spectrum of a disease that is difficult to define. Dig Dis Sci. 2011 Jul; 56(7):1923-5.
    View in: PubMed
  26. McIntire MG, Soucy G, Vaughan TL, Shahsafaei A, Odze RD. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol. 2011 Jul; 35(7):1007-13.
    View in: PubMed
  27. Odze RD. What the gastroenterologist needs to know about the histology of Barrett's esophagus. Curr Opin Gastroenterol. 2011 Jul; 27(4):389-96.
    View in: PubMed
  28. Long KB, Odze RD. Gastroesophageal junction hyperplastic (inflammatory) polyps: a clinical and pathologic study of 46 cases. Am J Surg Pathol. 2011 Jul; 35(7):1038-44.
    View in: PubMed
  29. Gibson JA, Hahn HP, Shahsafaei A, Odze RD. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Am J Surg Pathol. 2011 May; 35(5):742-9.
    View in: PubMed
  30. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, Wershil BK, Rothenberg ME, Aceves SS. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011 Jul; 128(1):3-20.e6; quiz 21-2.
    View in: PubMed
  31. Saboo SS, Krajewski KM, Jagannathan JP, O'Regan KN, Odze R, Ramaiya N, Wolpin BM. Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma. Cancer Imaging. 2011; 11:37-41.
    View in: PubMed
  32. Wu FM, Ukomadu C, Odze RD, Valente AM, Mayer JE, Earing MG. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011 May-Jun; 6(3):190-201.
    View in: PubMed
  33. Burakoff R, Chao S, Perencevich M, Ying J, Friedman S, Makrauer F, Odze R, Khurana H, Liew CC. Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis. 2011 Aug; 17(8):1719-25.
    View in: PubMed
  34. Coco DP, Goldblum JR, Hornick JL, Lauwers GY, Montgomery E, Srivastava A, Wang H, Odze RD. Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus. Am J Surg Pathol. 2011 Jan; 35(1):45-54.
    View in: PubMed
  35. Shyn PB, Mortele KJ, Britz-Cunningham SH, Friedman S, Odze RD, Burakoff R, Goldberg JE, Erturk M, Silverman SG. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease. J Nucl Med. 2010 Dec; 51(12):1841-8.
    View in: PubMed
  36. White CD, Khurana H, Gnatenko DV, Li Z, Odze RD, Sacks DB, Schmidt VA. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol. 2010; 10:125.
    View in: PubMed
  37. Lai LA, Kostadinov R, Barrett MT, Peiffer DA, Pokholok D, Odze R, Sanchez CA, Maley CC, Reid BJ, Gunderson KL, Rabinovitch PS. Deletion at fragile sites is a common and early event in Barrett's esophagus. Mol Cancer Res. 2010 Aug; 8(8):1084-94.
    View in: PubMed
  38. Odze RD, Maley CC. Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms. Arch Pathol Lab Med. 2010 Jun; 134(6):896-906.
    View in: PubMed
  39. Joo M, Odze RD. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol. 2010 May; 34(5):689-96.
    View in: PubMed
  40. Kim KM, Lee EJ, Kim YH, Chang DK, Odze RD. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol. 2010 May; 34(5):667-75.
    View in: PubMed
  41. Fleischer DE, Odze R, Overholt BF, Carroll J, Chang KJ, Das A, Goldblum J, Miller D, Lightdale CJ, Peters J, Rothstein R, Sharma VK, Smith D, Velanovich V, Wolfsen H, Triadafilopoulos G. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci. 2010 Jul; 55(7):1918-31.
    View in: PubMed
  42. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138(2):746-74, 774.e1-4; quiz e12-3.
    View in: PubMed
  43. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T, McLeod R, Burgart LJ, Allen J, Brill JV. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138(2):738-45.
    View in: PubMed
  44. Tejpar S, Odze RD. Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer. Gastrointest Cancer Res. 2009 Sep; 3(5 Supplement 2):S73-8.
    View in: PubMed
  45. Riddell RH, Odze RD. Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead? Am J Gastroenterol. 2009 Oct; 104(10):2588-94.
    View in: PubMed
  46. Chen YB, Kim HT, McDonough S, Odze RD, Yao X, Lazo-Kallanian S, Spitzer TR, Soiffer R, Antin JH, Ritz J. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2009 Sep; 15(9):1066-76.
    View in: PubMed
  47. Odze RD. Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol. 2009 Aug; 6(8):478-90.
    View in: PubMed
  48. Hahn HP, Blount PL, Ayub K, Das KM, Souza R, Spechler S, Odze RD. Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol. 2009 Jul; 33(7):1006-15.
    View in: PubMed
  49. Glickman JN, Spechler SJ, Souza RF, Lunsford T, Lee E, Odze RD. Multilayered epithelium in mucosal biopsy specimens from the gastroesophageal junction region is a histologic marker of gastroesophageal reflux disease. Am J Surg Pathol. 2009 Jun; 33(6):818-25.
    View in: PubMed
  50. Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, Lauwers GY, Odze RD. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009 Jun; 33(6):854-62.
    View in: PubMed
  51. Rucker-Schmidt RL, Sanchez CA, Blount PL, Ayub K, Li X, Rabinovitch PS, Reid BJ, Odze RD. Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study. Am J Surg Pathol. 2009 Jun; 33(6):886-93.
    View in: PubMed
  52. Pagidipati N, Obstein KL, Rucker-Schmidt R, Odze RD, Thompson CC. Acute hepatitis due to epstein-barr virus in an immunocompetent patient. Dig Dis Sci. 2010 Apr; 55(4):1182-5.
    View in: PubMed
  53. Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, Reid BJ. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res. 2009 May 15; 15(10):3305-14.
    View in: PubMed
  54. Jankowski JA, Odze RD. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol. 2009 May; 104(5):1093-6.
    View in: PubMed
  55. Pouw RE, Gondrie JJ, Rygiel AM, Sondermeijer CM, ten Kate FJ, Odze RD, Vieth M, Krishnadath KK, Bergman JJ. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol. 2009 Jun; 104(6):1366-73.
    View in: PubMed
  56. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis. 2009 Apr; 15(4):630-8.
    View in: PubMed
  57. Liu W, Hahn H, Odze RD, Goyal RK. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol. 2009 Apr; 104(4):816-24.
    View in: PubMed
  58. Joo M, Shahsafaei A, Odze RD. Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway. Hum Pathol. 2009 Jun; 40(6):872-80.
    View in: PubMed
  59. Mortelé KJ, Peters HE, Odze RD, Glickman JN, Jajoo K, Banks PA. An unusual mixed tumor of the pancreas: sonographic and MDCT features. JOP. 2009; 10(2):204-8.
    View in: PubMed
  60. Yantiss RK, Odze RD. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol. 2009 Mar; 104(3):774-83.
    View in: PubMed
  61. Yantiss RK, Shia J, Klimstra DS, Hahn HP, Odze RD, Misdraji J. Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol. 2009 Feb; 33(2):248-55.
    View in: PubMed
  62. Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol. 2009 Feb; 104(2):485-90.
    View in: PubMed
  63. Odze RD, Lauwers GY. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008 Dec; 40(12):1008-15.
    View in: PubMed
  64. Paulson TG, Galipeau PC, Xu L, Kissel HD, Li X, Blount PL, Sanchez CA, Odze RD, Reid BJ. p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One. 2008; 3(11):e3809.
    View in: PubMed
  65. Chao DL, Sanchez CA, Galipeau PC, Blount PL, Paulson TG, Cowan DS, Ayub K, Odze RD, Rabinovitch PS, Reid BJ. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clin Cancer Res. 2008 Nov 1; 14(21):6988-95.
    View in: PubMed
  66. Hahn HP, Shahsafaei A, Odze RD. Vascular and lymphatic properties of the superficial and deep lamina propria in Barrett esophagus. Am J Surg Pathol. 2008 Oct; 32(10):1454-61.
    View in: PubMed
  67. Odze RD. Update on the diagnosis and treatment of Barrett esophagus and related neoplastic precursor lesions. Arch Pathol Lab Med. 2008 Oct; 132(10):1577-85.
    View in: PubMed
  68. Odze RD. What are the guidelines for treating adenoma-like DALMs in UC? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S243-4.
    View in: PubMed
  69. Glickman JN, Odze RD. Does rectal sparing ever occur in ulcerative colitis? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S166-7.
    View in: PubMed
  70. Zhang X, Huang Q, Goyal RK, Odze RD. DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions. Am J Surg Pathol. 2008 Sep; 32(9):1327-35.
    View in: PubMed
  71. Yantiss RK, Das KM, Farraye FA, Odze RD. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Am J Surg Pathol. 2008 Jun; 32(6):844-50.
    View in: PubMed
  72. Odze R. A Balancing view: Pathologist-clinician interaction is essential. Am J Gastroenterol. 2008 Jun; 103(6):1331-3.
    View in: PubMed
  73. Srivastava A, Redston M, Farraye FA, Yantiss RK, Odze RD. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol. 2008 Feb; 32(2):296-303.
    View in: PubMed
  74. Chen X, Qin R, Liu B, Ma Y, Su Y, Yang CS, Glickman JN, Odze RD, Shaheen NJ. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 2008; 8:1.
    View in: PubMed
  75. Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, Blount PL, Odze RD, Ayub K, Reid BJ, Vaughan TL. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer. 2008; 60(1):39-48.
    View in: PubMed
  76. Hornick JL, Mino-Kenudson M, Lauwers GY, Liu W, Goyal R, Odze RD. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol. 2008 Jan; 103(1):38-47.
    View in: PubMed
  77. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, Rabinovitch PS. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2649-55.
    View in: PubMed
  78. Shimizu M, Ban S, Odze RD. Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma. Gastroenterol Clin North Am. 2007 Dec; 36(4):797-811, v-vi.
    View in: PubMed
  79. Hornick JL, Odze RD. Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol Clin North Am. 2007 Dec; 36(4):775-96, v.
    View in: PubMed
  80. Siahpush SH, Vaughan TL, Lampe JN, Freeman R, Lewis S, Odze RD, Blount PL, Ayub K, Rabinovitch PS, Reid BJ, Chen C. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2387-95.
    View in: PubMed
  81. Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007 Nov; 31(11):1733-41.
    View in: PubMed
  82. Yantiss RK, Panczykowski A, Misdraji J, Hahn HP, Odze RD, Rennert H, Chen YT. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. Am J Surg Pathol. 2007 Nov; 31(11):1742-53.
    View in: PubMed
  83. Mino-Kenudson M, Hull MJ, Brown I, Muzikansky A, Srivastava A, Glickman J, Park DY, Zuckerberg L, Misdraji J, Odze RD, Lauwers GY. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc. 2007 Oct; 66(4):660-6; quiz 767, 769.
    View in: PubMed
  84. Yantiss RK, Oh KY, Chen YT, Redston M, Odze RD. Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. Am J Surg Pathol. 2007 Aug; 31(8):1238-45.
    View in: PubMed
  85. Farraye FA, Waye JD, Moscandrew M, Heeren TC, Odze RD. Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc. 2007 Sep; 66(3):519-29.
    View in: PubMed
  86. Liu W, Makrauer FL, Qamar AA, Jänne PA, Odze RD. Fulminant hepatic failure secondary to erlotinib. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):917-20.
    View in: PubMed
  87. Lai LA, Paulson TG, Li X, Sanchez CA, Maley C, Odze RD, Reid BJ, Rabinovitch PS. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer. 2007 Jun; 46(6):532-42.
    View in: PubMed
  88. Srivastava A, Hornick JL, Li X, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2007 Mar; 102(3):483-93; quiz 694.
    View in: PubMed
  89. Yantiss RK, Odze RD. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol. 2007 Apr; 102(4):890-904.
    View in: PubMed
  90. Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, Ayub K, Rabinovitch PS, Vaughan TL, Reid BJ. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med. 2007 Feb; 4(2):e67.
    View in: PubMed
  91. Hornick JL, Farraye FA, Odze RD. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas. Am J Surg Pathol. 2007 Feb; 31(2):207-15.
    View in: PubMed
  92. Odze RD, Goldblum JR. Low-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1419-20; author reply 1420.
    View in: PubMed
  93. Odze RD, Tomaszewski JE, Furth EE, Feldman MD, Diallo R, Poremba C, Becker I, Hoefler H, Goldblum JR, Rybicki LA, Alsaigh N, Fogt F. Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep. 2006 Nov; 16(5):1123-9.
    View in: PubMed
  94. Odze RD. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol. 2006 Oct; 59(10):1029-38.
    View in: PubMed
  95. Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol. 2006 Sep; 30(9):1175-83.
    View in: PubMed
  96. Kraly JR, Jones MR, Gomez DG, Dickerson JA, Harwood MM, Eggertson M, Paulson TG, Sanchez CA, Odze R, Feng Z, Reid BJ, Dovichi NJ. Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues. Anal Chem. 2006 Sep 1; 78(17):5977-86.
    View in: PubMed
  97. Pai RD, Fong DG, Bundga ME, Odze RD, Rattner DW, Thompson CC. Transcolonic endoscopic cholecystectomy: a NOTES survival study in a porcine model (with video). Gastrointest Endosc. 2006 Sep; 64(3):428-34.
    View in: PubMed
  98. Odze RD. Pathology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am. 2006 Sep; 35(3):533-52.
    View in: PubMed
  99. Finley JC, Reid BJ, Odze RD, Sanchez CA, Galipeau P, Li X, Self SG, Gollahon KA, Blount PL, Rabinovitch PS. Chromosomal instability in Barrett's esophagus is related to telomere shortening. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1451-7.
    View in: PubMed
  100. Glickman JN, Blount PL, Sanchez CA, Cowan DS, Wongsurawat VJ, Reid BJ, Odze RD. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus. Hum Pathol. 2006 Oct; 37(10):1304-15.
    View in: PubMed
  101. Dorer R, Odze RD. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol. 2006 Jul; 30(7):871-7.
    View in: PubMed
  102. Lomo LC, Blount PL, Sanchez CA, Li X, Galipeau PC, Cowan DS, Ayub K, Rabinovitch PS, Reid BJ, Odze RD. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol. 2006 Apr; 30(4):423-35.
    View in: PubMed
  103. Paulson TG, Xu L, Sanchez C, Blount PL, Ayub K, Odze RD, Reid BJ. Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res. 2006 Mar 15; 12(6):1701-6.
    View in: PubMed
  104. Wongsurawat VJ, Finley JC, Galipeau PC, Sanchez CA, Maley CC, Li X, Blount PL, Odze RD, Rabinovitch PS, Reid BJ. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev. 2006 Mar; 15(3):509-16.
    View in: PubMed
  105. Yantiss RK, Farraye FA, O'Brien MJ, Fruin AB, Stucchi AF, Becker JM, Reddy SI, Odze RD. Prognostic significance of superficial fissuring ulceration in patients with severe "indeterminate" colitis. Am J Surg Pathol. 2006 Feb; 30(2):165-70.
    View in: PubMed
  106. Hornick JL, Farraye FA, Odze RD. Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma. Am J Surg Pathol. 2006 Jan; 30(1):28-35.
    View in: PubMed
  107. Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology. 2006 Jan; 48(2):116-32.
    View in: PubMed
  108. Vaughan TL, Dong LM, Blount PL, Ayub K, Odze RD, Sanchez CA, Rabinovitch PS, Reid BJ. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol. 2005 Dec; 6(12):945-52.
    View in: PubMed
  109. Odze RD. Pathology of the gastroesophageal junction. Semin Diagn Pathol. 2005 Nov; 22(4):256-65.
    View in: PubMed
  110. Haskell H, Andrews CW, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, Becker JM, Odze RD. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005 Nov; 29(11):1472-81.
    View in: PubMed
  111. Kristal AR, Blount PL, Schenk JM, Sanchez CA, Rabinovitch PS, Odze RD, Standley J, Vaughan TL, Reid BJ. Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14(10):2377-83.
    View in: PubMed
  112. Odze RD, Glickman JN. Significance of squamous metaplasia-like change in the esophagus. Am J Surg Pathol. 2005 Sep; 29(9):1259-61; author reply 1261-3.
    View in: PubMed
  113. Odze RD. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol. 2005 Aug; 100(8):1853-67.
    View in: PubMed
  114. Hornick JL, Lauwers GY, Odze RD. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol. 2005 Mar; 29(3):381-9.
    View in: PubMed
  115. O'Connell FP, Wang HH, Odze RD. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med. 2005 Mar; 129(3):338-47.
    View in: PubMed
  116. Odze R. Giant esophageal papilloma. Gastrointest Endosc. 2005 Mar; 61(3):499-500; author reply 500-1.
    View in: PubMed
  117. Hornick JL, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol. 2005 Mar; 29(3):372-80.
    View in: PubMed
  118. Oh K, Redston M, Odze RD. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol. 2005 Jan; 36(1):101-11.
    View in: PubMed
  119. Glickman JN, Ormsby AH, Gramlich TL, Goldblum JR, Odze RD. Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus. Hum Pathol. 2005 Jan; 36(1):58-65.
    View in: PubMed
  120. Odze RD. Cell proliferation and differentiation in familial adenomatous polyposis. Hum Pathol. 2004 Nov; 35(11):1430-1.
    View in: PubMed
  121. Fogt F, Brown CA, Badizadegan K, Zimmerman RL, Odze R. Low prevalence of loss of heterozygosity and SMAD4 mutations in sporadic and familial juvenile polyposis syndrome-associated juvenile polyps. Am J Gastroenterol. 2004 Oct; 99(10):2025-31.
    View in: PubMed
  122. Yantiss RK, Sapp HL, Farraye FA, El-Zammar O, O'Brien MJ, Fruin AB, Stucchi AF, Brien TP, Becker JM, Odze RD. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004 Aug; 28(8):999-1006.
    View in: PubMed
  123. Pantanowitz L, Antonioli DA, Odze RD. Inflammatory fibroid polyps are not inflammatory myofibroblastic tumors. Diagn Cytopathol. 2004 Aug; 31(2):131.
    View in: PubMed
  124. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004 Jul; 2(7):534-41.
    View in: PubMed
  125. Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. J Thorac Cardiovasc Surg. 2004 Jun; 127(6):1579-86.
    View in: PubMed
  126. Odze RD. Pathology of indeterminate colitis. J Clin Gastroenterol. 2004 May-Jun; 38(5 Suppl 1):S36-40.
    View in: PubMed
  127. Mutinga ML, Odze RD, Wang HH, Hornick JL, Farraye FA. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis. 2004 May; 10(3):215-9.
    View in: PubMed
  128. Shaz BH, Reddy SI, Ayata G, Brien T, Farraye FA, Antonioli DA, Odze RD, Wang HH. Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol. 2004 Apr; 17(4):395-401.
    View in: PubMed
  129. Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, Leichtner AM, Odze RD. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004 Feb; 28(2):190-7.
    View in: PubMed
  130. Pantanowitz L, Antonioli DA, Pinkus GS, Shahsafaei A, Odze RD. Inflammatory fibroid polyps of the gastrointestinal tract: evidence for a dendritic cell origin. Am J Surg Pathol. 2004 Jan; 28(1):107-14.
    View in: PubMed
  131. Glickman JN, Shahsafaei A, Odze RD. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach. Am J Surg Pathol. 2003 Oct; 27(10):1357-65.
    View in: PubMed
  132. Friedman S, Odze RD, Farraye FA. Management of neoplastic polyps in inflammatory bowel disease. Inflamm Bowel Dis. 2003 Jul; 9(4):260-6.
    View in: PubMed
  133. Wieczorek TJ, Wang HH, Antonioli DA, Glickman JN, Odze RD. Pathologic features of reflux and Helicobacter pylori-associated carditis: a comparative study. Am J Surg Pathol. 2003 Jul; 27(7):960-8.
    View in: PubMed
  134. Yantiss RK, Odze RD, Farraye FA, Rosenberg AE. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol. 2003 Jun; 27(6):811-7.
    View in: PubMed
  135. Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol. 2003 Apr; 16(4):347-58.
    View in: PubMed
  136. Ayata G, Ithamukkala S, Sapp H, Shaz BH, Brien TP, Wang HH, Antonioli DA, Farraye FA, Odze RD. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol. 2002 Nov; 26(11):1414-23.
    View in: PubMed
  137. Sapp H, Ithamukkala S, Brien TP, Ayata G, Shaz B, Dorfman DM, Wang HH, Antonioli DA, Farraye FA, Odze RD. The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol. 2002 Nov; 26(11):1484-92.
    View in: PubMed
  138. Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD. Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol. 2002 Aug; 26(8):1032-9.
    View in: PubMed
  139. Yantiss RK, Chang HK, Farraye FA, Compton CC, Odze RD. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol. 2002 Jul; 26(7):893-901.
    View in: PubMed
  140. Odze R. Cytokeratin 7/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia? Lancet. 2002 May 18; 359(9319):1711-3.
    View in: PubMed
  141. Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, Goedegebuure PS, Eberlein TJ. Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer. 2002 May 15; 94(10):2552-60.
    View in: PubMed
  142. Odze RD, Brien T, Brown CA, Hartman CJ, Wellman A, Fogt F. Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis. Am J Gastroenterol. 2002 May; 97(5):1235-42.
    View in: PubMed
  143. Odze RD, Goldblum J, Noffsinger A, Alsaigh N, Rybicki LA, Fogt F. Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol. 2002 Apr; 15(4):379-86.
    View in: PubMed
  144. Yantiss RK, Bosenberg MW, Antonioli DA, Odze RD. Utility of MMP-1, p53, E-cadherin, and collagen IV immunohistochemical stains in the differential diagnosis of adenomas with misplaced epithelium versus adenomas with invasive adenocarcinoma. Am J Surg Pathol. 2002 Feb; 26(2):206-15.
    View in: PubMed
  145. Fogt F, Brien T, Brown CA, Hartmann CJ, Zimmerman RL, Odze RD. Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol. 2002 Jan; 33(1):87-91.
    View in: PubMed
  146. Shields HM, Rosenberg SJ, Zwas FR, Ransil BJ, Lembo AJ, Odze R. Prospective evaluation of multilayered epithelium in Barrett's esophagus. Am J Gastroenterol. 2001 Dec; 96(12):3268-73.
    View in: PubMed
  147. Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol. 2001 Nov; 32(11):1157-65.
    View in: PubMed
  148. Cai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol. 2001 Oct; 32(10):1087-93.
    View in: PubMed
  149. Yantiss RK, Goldman H, Odze RD. Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases. Mod Pathol. 2001 Sep; 14(9):869-75.
    View in: PubMed
  150. Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H, Shaw R, Brien TP, Bozzuto CD, Ooi D, Cantley LC, Yuan J. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell. 2001 Jun; 7(6):1307-19.
    View in: PubMed
  151. Brien TP, Farraye FA, Odze RD. Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases. Mod Pathol. 2001 May; 14(5):389-96.
    View in: PubMed
  152. Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol. 2001 May; 25(5):569-78.
    View in: PubMed
  153. Kulke MH, Thakore KS, Thomas G, Wang H, Loda M, Eng C, Odze RD. Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma. Cancer. 2001 Apr 15; 91(8):1451-7.
    View in: PubMed
  154. Kulke MH, Odze RD, Thakore KS, Thomas G, Wang H, Loda M, Eng C. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Br J Cancer. 2001 Mar 23; 84(6):748-53.
    View in: PubMed
  155. Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol. 2001 Jan; 25(1):87-94.
    View in: PubMed
  156. Odze RD, Brown CA, Hartmann CJ, Noffsinger AE, Fogt F. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol. 2000 Sep; 24(9):1209-16.
    View in: PubMed
  157. Turner JR, Torres CM, Wang HH, Shahsafaei A, Richards WG, Sugarbaker D, Odze RD. Preoperative chemoradiotherapy alters the expression and prognostic significance of adhesion molecules in Barrett's-associated adenocarcinoma. Hum Pathol. 2000 Mar; 31(3):347-53.
    View in: PubMed
  158. Brien TP, Odze RD, Sheehan CE, McKenna BJ, Ross JS. HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma. Hum Pathol. 2000 Jan; 31(1):35-9.
    View in: PubMed
  159. Chen YY, Wang HH, Antonioli DA, Spechler SJ, Zeroogian JM, Goyal R, Shahsafaei A, Odze RD. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol. 1999 Dec; 30(12):1488-95.
    View in: PubMed
  160. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999 Dec; 117(6):1288-94; discussion 1488-91.
    View in: PubMed
  161. Walsh S, Murphy M, Silverman M, Odze R, Antonioli D, Goldman H, Loda M. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis. Am J Pathol. 1999 Nov; 155(5):1511-8.
    View in: PubMed
  162. Torres CM, Wang HH, Turner JR, Richards W, Sugarbaker D, Shahsafaei A, Odze RD. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy. Mod Pathol. 1999 Oct; 12(10):961-8.
    View in: PubMed
  163. Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol. 1999 Aug; 23(8):963-9.
    View in: PubMed
  164. Odze RD. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999 Jul; 94(7):1746-50.
    View in: PubMed
  165. Thurberg BL, Duray PH, Odze RD. Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases. Hum Pathol. 1999 Jul; 30(7):745-52.
    View in: PubMed
  166. Torres C, Wang H, Turner J, Shahsafaei A, Odze RD. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum Pathol. 1999 Jul; 30(7):753-8.
    View in: PubMed
  167. Tobi M, Kaila V, Hassan N, Gallinger S, Fligiel S, Hatfield J, Gesell M, Sakr W, Luk G, Odze RD. Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine. Hum Pathol. 1999 Apr; 30(4):467-73.
    View in: PubMed
  168. Gulizia JM, Wang H, Antonioli D, Spechler SJ, Zeroogian J, Goyal R, Shahsafaei A, Chen YY, Odze RD. Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. Hum Pathol. 1999 Apr; 30(4):412-8.
    View in: PubMed
  169. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, Sugarbaker DJ, Odze RD. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer. 1999 Feb 15; 85(4):769-78.
    View in: PubMed
  170. Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, Odze RD. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients. Cancer. 1999 Feb 1; 85(3):520-8.
    View in: PubMed
  171. Jenkins TD, Mueller A, Odze R, Shahsafaei A, Zukerberg LR, Kent R, Stoner GD, Rustgi AK. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium. Oncogene. 1999 Jan 7; 18(1):59-66.
    View in: PubMed
  172. Odze RD. Skip lesions in ulcerative colitis. Am J Gastroenterol. 1998 Nov; 93(11):2307.
    View in: PubMed
  173. Kraus MD, Shahsafaei A, Antin J, Odze RD. Relationship of Bcl-2 expression with apoptosis and proliferation in colonic graft versus host disease. Hum Pathol. 1998 Aug; 29(8):869-75.
    View in: PubMed
  174. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol. 1998 Mar; 22(3):275-84.
    View in: PubMed
  175. Odze RD. Gastric fundic gland polyps: are they preneoplastic lesions? Gastroenterology. 1998 Feb; 114(2):422-3.
    View in: PubMed
  176. Singh SP, Odze RD. Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases. Am J Surg Pathol. 1998 Jan; 22(1):93-9.
    View in: PubMed
  177. Kraus MD, Feran-Doza M, Garcia-Moliner ML, Antin J, Odze RD. Cytomegalovirus infection in the colon of bone marrow transplantation patients. Mod Pathol. 1998 Jan; 11(1):29-36.
    View in: PubMed
  178. Mueller A, Odze R, Jenkins TD, Shahsesfaei A, Nakagawa H, Inomoto T, Rustgi AK. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res. 1997 Dec 15; 57(24):5542-9.
    View in: PubMed
  179. Turner JR, Odze RD, Crum CP, Resnick MB. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. Hum Pathol. 1997 Jun; 28(6):740-4.
    View in: PubMed
  180. Nakagawa H, Wang TC, Zukerberg L, Odze R, Togawa K, May GH, Wilson J, Rustgi AK. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene. 1997 Mar 13; 14(10):1185-90.
    View in: PubMed
  181. Yacoub L, Goldman H, Odze RD. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Mod Pathol. 1997 Feb; 10(2):105-12.
    View in: PubMed
  182. Turner JR, Shen LH, Crum CP, Dean PJ, Odze RD. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol. 1997 Feb; 28(2):174-8.
    View in: PubMed
  183. Odze RD, Marcial MA, Antonioli D. Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. Hum Pathol. 1996 Sep; 27(9):896-903.
    View in: PubMed
  184. Alsaigh N, Odze R, Goldman H, Antonioli D, Ott MJ, Leichtner A. Gastric and esophageal intraepithelial lymphocytes in pediatric celiac disease. Am J Surg Pathol. 1996 Jul; 20(7):865-70.
    View in: PubMed
  185. Zhuang Z, Vortmeyer AO, Mark EJ, Odze R, Emmert-Buck MR, Merino MJ, Moon H, Liotta LA, Duray PH. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res. 1996 May 1; 56(9):1961-4.
    View in: PubMed
  186. Turner JR, Odze RD. Proliferative characteristics of differentiated cells in familial adenomatous polyposis-associated duodenal adenomas. Hum Pathol. 1996 Jan; 27(1):63-9.
    View in: PubMed
  187. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology. 1996 Jan; 110(1):155-66.
    View in: PubMed
  188. Odze RD. Epithelial proliferation and differentiation in flat duodenal mucosa of patients with familial adenomatous polyposis. Mod Pathol. 1995 Aug; 8(6):648-53.
    View in: PubMed
  189. Resnick MB, Gallinger S, Wang HH, Odze RD. Growth factor expression and proliferation kinetics in periampullary neoplasms in familial adenomatous polyposis. Cancer. 1995 Jul 15; 76(2):187-94.
    View in: PubMed
  190. Gallinger S, Vivona AA, Odze RD, Mitri A, O'Beirne CP, Berk TC, Bapat BV. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients. Oncogene. 1995 May 4; 10(9):1875-8.
    View in: PubMed
  191. Odze RD, Wershil BK, Leichtner AM, Antonioli DA. Allergic colitis in infants. J Pediatr. 1995 Feb; 126(2):163-70.
    View in: PubMed
  192. Odze RD, Medline P, Cohen Z. Adenocarcinoma arising in an appendix involved with chronic ulcerative colitis. Am J Gastroenterol. 1994 Oct; 89(10):1905-7.
    View in: PubMed
  193. Apel R, Cohen Z, Andrews CW, McLeod R, Steinhart H, Odze RD. Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology. 1994 Aug; 107(2):435-43.
    View in: PubMed
  194. Odze R, Gallinger S, So K, Antonioli D. Duodenal adenomas in familial adenomatous polyposis: relation of cell differentiation and mucin histochemical features to growth pattern. Mod Pathol. 1994 Apr; 7(3):376-84.
    View in: PubMed
  195. Bapat B, Odze R, Mitri A, Berk T, Ward M, Gallinger S. Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet. 1993 Nov; 2(11):1957-9.
    View in: PubMed
  196. Odze R, Antonioli D, Peppercorn M, Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol. 1993 Sep; 17(9):869-75.
    View in: PubMed
  197. Odze R, Antonioli D, Shocket D, Noble-Topham S, Goldman H, Upton M. Esophageal squamous papillomas. A clinicopathologic study of 38 lesions and analysis for human papillomavirus by the polymerase chain reaction. Am J Surg Pathol. 1993 Aug; 17(8):803-12.
    View in: PubMed
  198. Odze RD, Bines J, Leichtner AM, Goldman H, Antonioli DA. Allergic proctocolitis in infants: a prospective clinicopathologic biopsy study. Hum Pathol. 1993 Jun; 24(6):668-74.
    View in: PubMed
  199. Odze RD, Quinn PS, Terrault NA, Vivona AA, Ward MA, Cohen Z, Gallinger S. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol. 1993 Apr; 24(4):442-8.
    View in: PubMed
  200. Gallinger S, Reilly RM, Kirsh JC, Odze RD, Schmocker BJ, Hay K, Polihronis J, Damani MT, Shpitz B, Stern HS. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients. Cancer Res. 1993 Jan 15; 53(2):271-8.
    View in: PubMed
  201. Reilly RM, Kirsh J, Gallinger S, Thiessen JJ, Damani M, Hay K, Polihronis J, Schmocker B, Odze R, Houle S, et al. Compartmental analysis of the pharmacokinetics of radioiodinated monoclonal antibody B72.3 in colon cancer patients. Nucl Med Biol. 1993 Jan; 20(1):57-64.
    View in: PubMed
  202. Odze RD, Bégin LR. Peptic-ulcer-induced aortoenteric fistula. Report of a case and review of the literature. J Clin Gastroenterol. 1991 Dec; 13(6):682-6.
    View in: PubMed
  203. Odze R, Bégin LR. Malignant paraganglioma of the posterior mediastinum. A case report and review of the literature. Cancer. 1990 Feb 1; 65(3):564-9.
    View in: PubMed
  204. Dalrymple S, Odze R, Gordon PH, Mitmaker B. Enhanced carcinogenesis in the proximal small intestine of the rat following rumenectomy. Clin Invest Med. 1989 Apr; 12(2):110-4.
    View in: PubMed
  205. Odze R, Bégin LR. Tubular adenomatous metaplasia (nephrogenic adenoma) of the female urethra. Int J Gynecol Pathol. 1989; 8(4):374-80.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Odze's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_